Skip to main content

Advertisement

SpringerLink
Log in

Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens

  • Original Article
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

The purpose of our study was to investigate the expression of prostate stem cell antigen (PSCA), piwi-like 1 (PIWIL1) and T-box 2 (TBX2) and its correlation with HPV16 infection in cervical squamous cell carcinoma (CSCC). HPV16 was detected by amplifying the HPV16 E7 gene by the polymerase chain reaction (PCR) method, and the expression of PSCA, PIWIL1, TBX2 and HPV16 E7 in 59 CSCCs and matched adjacent normal cervix (MANC) was examined by the streptavidin-peroxidase (SP) method. Fifty-two CSCCs and MANC specimens that were positive for the E7 gene and the E7 protein were identified as infected with HPV16 and included in present study. The rate of infection with HPV16 in CSCC was 52% (27/52), but that in matched adjacent normal cervix (MANC) samples was 4% (2/52). Infection with HPV16 was found to be statistically more frequent in CSCC (P = 0.000). The expression rates of PSCA, PIWIL1 and TBX2 in MANC were 6% (3/52), 8% (4/52) and 2% (1/52), respectively, but those in CSCC were 62% (32/52), 75% (39/52) and 52% (27/52), respectively. Higher expression rates of PSCA, PIWIL1 and TBX2 were observed in CSCC than in MANC (P = 0.000). HPV16 had a statistical positive correlation with PSCA, PIWIL1 and TBX2 in CSCC (P < 0.05). The increased expression of PSCA, PIWIL1 and TBX2 had no correlation with the patient’s age or histological grade P > 0.05). The elevated expression of PSCA and PIWIL1 was associated with invasion of CSCC (P < 0.05). Up-regulated expression of TBX2 had a positive association with lymph node metastasis (P = 0.014). These findings demonstrate for the first time the expression of PSCA, PIWIL1 and TBX2 in CSCC. Their correlation with HPV16 might provide new basic information for investigating the molecular mechanism of HPV and help us to deepen our understanding of the interaction between HPV16 and host cells the carcinogenesis of CSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Roden R, Wu TC (2006) How will HPV vaccines affect cervical cancer? Nat Rev Cancer 6:753–763

    Article  PubMed  CAS  Google Scholar 

  2. Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1–17

    Article  PubMed  CAS  Google Scholar 

  3. Scheffner M, Werness BA, Huibregtse JM et al (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136

    Article  PubMed  CAS  Google Scholar 

  4. Huibregtse JM, Scheffner M, Howley PM (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10:4129–4135

    PubMed  CAS  Google Scholar 

  5. Scheffner M, Huibregtse JM, Vierstra RD et al (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505

    Article  PubMed  CAS  Google Scholar 

  6. Chellappan S, Kraus VB, Kroger B et al (1992) Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 89:4549–4553

    Article  PubMed  CAS  Google Scholar 

  7. Boyer SN, Wazer DE, Band V (1996) E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620–4624

    PubMed  CAS  Google Scholar 

  8. Jones DL, Thompson DA, Munger K (1997) Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 239:97–107

    Article  PubMed  CAS  Google Scholar 

  9. Munger K, Baldwin A, Edwards KM et al (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78:11451–11460

    Article  PubMed  CAS  Google Scholar 

  10. Gangemi R, Paleari L, Orengo AM et al (2009) Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 16:1688–1703

    Article  PubMed  CAS  Google Scholar 

  11. Reiter RE, Gu Z, Watabe T et al (1998) Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 95:1735–1740

    Article  PubMed  CAS  Google Scholar 

  12. Gu Z, Thomas G, Yamashiro J et al (2000) Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19:1288–1296

    Article  PubMed  CAS  Google Scholar 

  13. Ross S, Spencer SD, Holcomb I et al (2002) Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res 62:2546–2553

    PubMed  CAS  Google Scholar 

  14. Amara N, Palapattu GS, Schrage M et al (2001) Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res 61:4660–4665

    PubMed  CAS  Google Scholar 

  15. Argani P, Rosty C, Reiter RE et al (2001) Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 61:4320–4324

    PubMed  CAS  Google Scholar 

  16. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL et al (2002) Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 160:1239–1249

    PubMed  CAS  Google Scholar 

  17. Wente MN, Jain A, Kono E et al (2005) Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer. Pancreas 31:119–125

    Article  PubMed  CAS  Google Scholar 

  18. Elsamman E, Fukumori T, Kasai T et al (2006) Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder. BJU Int 97:1202–1207

    Article  PubMed  CAS  Google Scholar 

  19. Elsamman EM, Fukumori T, Tanimoto S et al (2006) The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. BJU Int 98:668–673

    Article  PubMed  CAS  Google Scholar 

  20. Sakamoto H, Yoshimura K, Saeki N et al (2008) Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 40:730–740

    Article  PubMed  CAS  Google Scholar 

  21. Rowley M, Grothey E, Couch FJ (2004) The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia 9:109–118

    Article  PubMed  Google Scholar 

  22. Papaioannou VE, Silver LM (1998) The T-box gene family. Bioessays 20:9–19

    Article  PubMed  CAS  Google Scholar 

  23. Harrelson Z, Kelly RG, Goldin SN et al (2004) Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131:5041–5052

    Article  PubMed  CAS  Google Scholar 

  24. Barlund M, Monni O, Kononen J et al (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res 60:5340–5344

    PubMed  CAS  Google Scholar 

  25. Mahlamaki EH, Barlund M, Tanner M et al (2002) Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35:353–358

    Article  PubMed  CAS  Google Scholar 

  26. Sinclair CS, Adem C, Naderi A et al (2002) TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res 62:3587–3591

    PubMed  CAS  Google Scholar 

  27. Jacobs JJ, Keblusek P, Robanus-Maandag E et al (2000) Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 26:291–299

    Article  PubMed  CAS  Google Scholar 

  28. Fan W, Huang X, Chen C et al (2004) TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines. Cancer Res 64:5132–5139

    Article  PubMed  CAS  Google Scholar 

  29. Grochola LF, Greither T, Taubert H et al (2008) The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br J Cancer 99:1083–1088

    Article  PubMed  CAS  Google Scholar 

  30. Lingel A, Sattler M (2005) Novel modes of protein-RNA recognition in the RNAi pathway. Curr Opin Struct Biol 15:107–115

    Article  PubMed  CAS  Google Scholar 

  31. Qiao D, Zeeman AM, Deng W et al (2002) Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 21:3988–3999

    Article  PubMed  CAS  Google Scholar 

  32. Lee JH, Schutte D, Wulf G et al (2006) Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 15:201–211

    Article  PubMed  CAS  Google Scholar 

  33. Liu X, Sun Y, Guo J et al (2006) Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int J Cancer 118:1922–1929

    Article  PubMed  CAS  Google Scholar 

  34. Taubert H, Greither T, Kaushal D et al (2007) Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 26:1098–1100

    Article  PubMed  CAS  Google Scholar 

  35. Taubert H, Wurl P, Greither T et al (2007) Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients. Oncogene 26:7170–7174

    Article  PubMed  CAS  Google Scholar 

  36. Hermanek P, Sobin LH, International Union against Cancer (1987) TNM classification of malignant tumours, 4th, fully revised edn. Springer-Verlag, New York

    Google Scholar 

  37. Gall K, Pavicic D, Pavelic J et al (1993) PCR amplification of DNA from stained cytological smears. J Clin Pathol 46:378–379

    Article  PubMed  CAS  Google Scholar 

  38. Zhou Y, Pan Y, Zhang S et al (2007) Increased phosphorylation of p70 S6 kinase is associated with HPV16 infection in cervical cancer and esophageal cancer. Br J Cancer 97:218–222

    Article  PubMed  CAS  Google Scholar 

  39. Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265

    PubMed  CAS  Google Scholar 

  40. Ribacka C, Pesonen S, Hemminki A (2008) Cancer, stem cells, and oncolytic viruses. Ann Med 40:496–505

    Article  PubMed  CAS  Google Scholar 

  41. Soltysova A, Altanerova V, Altaner C (2005) Cancer stem cells. Neoplasma 52:435–440

    PubMed  CAS  Google Scholar 

  42. Zhigang Z, Wenlv S (2004) Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer. World J Surg Oncol 2:13

    Article  PubMed  Google Scholar 

  43. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342–350

    Article  PubMed  CAS  Google Scholar 

  44. Kim KH, Yoon DJ, Moon YA et al (1994) Expression and localization of human papillomavirus type 16 E6 and E7 open reading frame proteins in human epidermal keratinocyte. Yonsei Med J 35:1–9

    PubMed  Google Scholar 

  45. Smotkin D, Wettstein FO (1987) The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 61:1686–1689

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Scientific Research Foundation of the Health Ministry of Shaanxi Province in China (NO. 08D03) and the Scientific Research Foundation of postdoctor in China (NO.20090451383).

Conflict of interest statement

None.

Author information

Authors and Affiliations

  1. The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Biomedical Engineering Postdoctoral Research Station, School of Life Science and Technology, Xi’an Jiaotong University, 710049, Xi’an, Shaanxi Province, People’s Republic of China

    Wen-Kang Liu & Zhen-Xi Zhang

  2. Department of Gynecology and Obstetrics, Renmin Hospital, 710061, Xi’an, Shaanxi Province, People’s Republic of China

    Xiang-Yang Jiang

Authors
  1. Wen-Kang Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiang-Yang Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhen-Xi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen-Kang Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, WK., Jiang, XY. & Zhang, ZX. Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens. Arch Virol 155, 657–663 (2010). https://doi.org/10.1007/s00705-010-0635-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-010-0635-y

Keywords

Search

Navigation